Ruijin Li

Title: The Innovative Contributions of Ruijin Li

Introduction

Ruijin Li is a prominent inventor based in Beijing, China. He has made significant contributions to the field of pharmaceuticals, particularly through his innovative patent related to acrylamide compounds. His work focuses on addressing critical health issues, showcasing his dedication to advancing medical science.

Latest Patents

Ruijin Li holds a patent for the compound titled (2E)-3-phenyl-N-[2,2,2-Trifluoro-1-[[8-quinolineamino)thiomethyl]amino]ethyl]-2-acrylamide and its pharmaceutical uses. This invention relates to an acrylamide compound of Formula I, or an isomer, pharmaceutically acceptable salt, and solvate thereof. The patent also covers a composition comprising the compound and a pharmaceutically acceptable carrier, excipient, or diluent. The compound is intended for the prophylaxis and/or treatment of diseases or disorders associated with cardiomyocyte apoptosis. Ruijin Li has 1 patent to his name, reflecting his innovative contributions to the field.

Career Highlights

Ruijin Li is affiliated with the Chinese PLA General Hospital, where he applies his expertise in pharmaceuticals and research. His role at this esteemed institution allows him to collaborate with other professionals and contribute to significant advancements in medical treatments.

Collaborations

Some of Ruijin Li's notable coworkers include Kunlun He and Song Li. Their collaborative efforts in research and development have further enhanced the impact of their work in the pharmaceutical field.

Conclusion

Ruijin Li's innovative work and dedication to pharmaceutical research exemplify the vital role of inventors in advancing medical science. His contributions, particularly through his patent, highlight the importance of innovation in addressing health challenges.